Flightpath

Flightpath Biosciences is dedicated to advancing therapies for pathogen-driven diseases, focusing on eradicating rare infectious conditions. Our seasoned R&D team, supported by distinguished scientists renowned for their track record of success, leverages advanced drug discovery tools. We prioritize precision in antimicrobial therapy to optimize drug targeting and safety, minimizing off-target effects on the microbiome. This approach accelerates time-to-market and mitigates antibiotic resistance risks. Concurrently, our data science and bioinformatics partners explore host and microbiome genetics and transcriptomics, enhancing our understanding of drug impacts on immune systems and overall health. At Flightpath Biosciences, we are committed to pioneering new data-driven insights and identifying targeted therapeutic solutions.